Neven H.
- Country
- Croatia
- Department
- Psychiatry
Research Overview
- Evaluation of Masupirdine (SUVN-502) Efficacy and Safety in Treating Agitation in Alzheimer's Dementia: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide/Quinidine Sulfate) in Treating Agitation in Alzheimer's Dementia Patients
- Long-Term Safety and Tolerability Assessment of Trospium Chloride and Xanomeline Tartrate in Psychosis Associated with Alzheimer's Disease
Data & Insights
Has run more than one trial at 82 of 176 partner sites.
Specializations
Neuropsychiatric Disorders
This investigator specializes in studying treatment approaches for bipolar I disorder, with particular emphasis on managing manic episodes and episodes with mixed features. Their research encompasses innovative therapeutic interventions for mood regulation and symptom management.
- Bipolar Mania Management
- Mixed Episode Treatment
- Mood Regulation Therapy
Neurodegenerative Conditions
The investigator focuses on addressing complex manifestations of Alzheimer's disease, particularly studying interventions for associated psychosis and agitation. Their work extends to evaluating long-term therapeutic solutions for these challenging symptoms.
- Alzheimer's-Related Psychosis
- Dementia-Associated Agitation
- Long-term Symptom Management
Movement Disorders
The investigator conducts research in the treatment of tardive dyskinesia, particularly in patients with various underlying conditions including schizophrenia, schizoaffective disorder, and mood disorders. Their work involves evaluating therapeutic interventions for movement disorder management.
- Tardive Dyskinesia Treatment
- Movement Disorder Management
- Neurological Symptom Control
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.